1
|
Hayman DTS, Barraclough RK, Muglia LJ, McGovern V, Afolabi MO, N'Jai AU, Ambe JR, Atim C, McClelland A, Paterson B, Ijaz K, Lasley J, Ahsan Q, Garfield R, Chittenden K, Phelan AL, Lopez Rivera A. Addressing the challenges of implementing evidence-based prioritisation in global health. BMJ Glob Health 2023; 8:e012450. [PMID: 37290897 PMCID: PMC10255200 DOI: 10.1136/bmjgh-2023-012450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Accepted: 05/14/2023] [Indexed: 06/10/2023] Open
Abstract
Global health requires evidence-based approaches to improve health and decrease inequalities. In a roundtable discussion between health practitioners, funders, academics and policy-makers, we recognised key areas for improvement to deliver better-informed, sustainable and equitable global health practices. These focus on considering information-sharing mechanisms and developing evidence-based frameworks that take an adaptive function-based approach, grounded in the ability to perform and respond to prioritised needs. Increasing social engagement as well as sector and participant diversity in whole-of-society decision-making, and collaborating with and optimising on hyperlocal and global regional entities, will improve prioritisation of global health capabilities. Since the skills required to navigate drivers of pandemics, and the challenges in prioritising, capacity building and response do not sit squarely in the health sector, it is essential to integrate expertise from a broad range of fields to maximise on available knowledge during decision-making and system development. Here, we review the current assessment tools and provide seven discussion points for how improvements to implementation of evidence-based prioritisation can improve global health.
Collapse
Affiliation(s)
- David T S Hayman
- Molecular Epidemiology and Public Health Laboratory, Massey University, Palmerston North, New Zealand
| | - Rosemary K Barraclough
- Molecular Epidemiology and Public Health Laboratory, Massey University, Palmerston North, New Zealand
| | - Louis J Muglia
- Burroughs Wellcome Fund, Research Triangle Park, North Carolina, USA
| | - Victoria McGovern
- Burroughs Wellcome Fund, Research Triangle Park, North Carolina, USA
| | - Muhammed O Afolabi
- Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK
| | - Alhaji U N'Jai
- Department of Microbiology, University of Sierra Leone College of Medicine and Allied Health Sciences, Freetown, Sierra Leone
- Department of Biological Sciences, University of Sierra Leone Fourah Bay College, Freetown, Sierra Leone
| | - Jennyfer R Ambe
- The Global Emerging Pathogens Treatment Consortium, Lagos, Nigeria
| | - Chris Atim
- Results for Development (R4D), Accra, Ghana
| | | | - Beverley Paterson
- Australian National University, Canberra, Australian Capital Territory, Australia
| | - Kashef Ijaz
- Health Programs, The Carter Center, Atlanta, Georgia, USA
| | | | - Qadeer Ahsan
- Australia Indonesia Health Security Partnership, Jakarta, Indonesia
| | | | | | - Alexandra L Phelan
- Center for Health Security, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Abigail Lopez Rivera
- US Department of Health and Human Services, Washington, District of Columbia, USA
| |
Collapse
|